Recursive’s $400 million outlay represents the bulk of the company’s fundraising to date.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Most people assume Python in Excel is something you use for complex data analysis. I found it useful for a much simpler reason: it helped me deal with the spreadsheet jobs I normally leave until later ...

News headlines Recursion Pharmaceuticals reported mixed Q2 2026 results, with revenues dropping significantly while narrowing losses. The company highlighted key milestones in its AI-driven drug ...

Formula One boss Stefano Domenicali heaped praise on teenager Kimi Antonelli on ‌Wednesday as the sport gave itself a glowing half-term report, with sold-out races and booming viewing figures in key ...

Amanda Bellucco-Chatham is an editor, writer, and fact-checker with years of experience researching personal finance topics. Specialties include general financial planning, career development, lending ...

The 2026 Formula 1 season started at Melbourne Park with the Australian Grand Prix on the weekend of March 6-8. Lando Norris became world champion for the first time in 2025 after finishing third at a ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Charlene Rhinehart is a CPA , CFE, chair of an Illinois CPA Society committee, and has a degree in accounting and ...

View the basic RXRX option chain and compare options of Recursion Pharmaceuticals, Inc. on Yahoo Finance.